Akili, Inc. EBITDA
- 2024-03-31: Basis Reported; EBITDA -$10.79M*; Operating income -$10.87M; Depreciation and amortization $75.00K.
- 2023-09-30: Basis Reported; EBITDA (m); Operating income -$18.43M; Depreciation and amortization (m).
- 2023-06-30: Basis Reported; EBITDA (m); Operating income -$15.32M; Depreciation and amortization (m).
- 2023-03-31: Basis Reported; EBITDA -$19.04M*; Operating income -$19.12M; Depreciation and amortization $77.00K.
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2024-03-31 | Reported | -$10.79M* | -$10.87M | $75.00K | $383.00K | -2817.23%* | $3.00K | -$10.00M | (m) | $4.18M | $6.89M | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$18.43M | (m) | $702.00K | (m) | (m) | (m) | (m) | $4.91M | $13.94M | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$15.32M | (m) | $114.00K | (m) | (m) | (m) | (m) | $4.63M | $10.65M | $0.00 |
|---|
| 2023-03-31 | Reported | -$19.04M* | -$19.12M | $77.00K | $113.00K | -16851.33%* | $3.00K | -$19.10M | (m) | $6.08M | $13.01M | $0.00 |
|---|
| 2022-09-30 | Reported | (m) | -$24.51M | (m) | $82.00K | (m) | (m) | (m) | (m) | $7.55M | $16.91M | $0.00 |
|---|
| 2022-06-30 | Reported | (m) | -$22.34M | (m) | $64.00K | (m) | (m) | (m) | (m) | $7.36M | $14.95M | $0.00 |
|---|
| 2022-03-31 | Reported | -$21.65M* | -$21.73M | $77.00K | $66.00K | -32800.00%* | $10.00K | -$22.23M | (m) | $6.30M | $15.39M | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$17.98M | (m) | $155.00K | (m) | (m) | (m) | (m) | $4.76M | $13.29M | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$143.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2023-12-31 | Reported | -$64.18M* | -$64.48M | $302.00K | $1.68M | -3824.97%* | $19.00K | -$57.87M | (m) | $19.93M | $45.42M | $53.00K |
|---|
| 2022-12-31 | Reported | -$90.37M* | -$90.68M | $308.00K | $323.00K | -27978.02%* | $42.00K | -$83.52M | (m) | $28.86M | $61.70M | $19.00K |
|---|
| 2021-12-31 | Reported | -$60.44M* | -$60.72M | $279.00K | $538.00K | -11234.20%* | $65.00K | -$53.98M | (m) | $18.23M | $42.67M | (m) |
|---|